Top Markets
#1 Islamic Coin Islamic Coin +154.27%
#2 PulseChain PulseChain +52.83%
#3 BOOK OF MEME BOOK OF MEME +44.89%
#4 DogBull DogBull +34.92%
#5 Nockchain Nockchain +18.68%
#6 ORDI ORDI +17.36%
#7 Ergo Ergo +17.32%
#8 rsERG rsERG +16.99%
#9 Bio Protocol Bio Protocol +16.75%
#10 PondCoin PondCoin +16.22%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Classement en actions #27024
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Prix de l'action
$0.16240909
Dernière synchronisation: 2025-03-04
Capitalisation boursière
$35.68M
Changement (1 jour)
0.27%
Changement (1 an)
0.00%
Pays
CN
Échange Dali Pharmaceuticalco.,Ltd (603963)

Catégorie

Healthcare
Ratio P/S pour Dali Pharmaceuticalco.,Ltd (603963)
Ratio P/S au August 2026 TTM : 2.97
Selon les derniers rapports financiers et le cours de l'action de Dali Pharmaceuticalco.,Ltd, le ratio cours/ventes actuel (TTM) est 2.97. À la fin de 2022, le ratio P/S était de 21.68.
Historique du ratio P/S pour Dali Pharmaceuticalco.,Ltd de 2012 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
2026 (TTM) 2.97 -90.20%
2023 30.30 39.75%
2022 21.68 91.44%
2021 11.32 41.15%
2020 8.02 23.66%
2019 6.49 60.68%
2018 4.04 -47.25%
2017 7.66 55.55%
2016 4.92 16.41%
2015 4.23 57.93%
2014 2.68 -12.09%
2013 3.04 -4.22%
2012 3.18 0.00%
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
7.73 160.20%
IN